Xie Yaxiong, Trouba Kevin J, Liu Jie, Waalkes Michael P, Germolec Dori R
Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709, USA.
Environ Health Perspect. 2004 Aug;112(12):1255-63. doi: 10.1289/txg.7152.
Previous research demonstrated that 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment increased the number of skin papillomas in v-Ha-ras transgenic (Tg.AC) mice that had received sodium arsenite [(As(III)] in drinking water, indicating that this model is useful for studying the toxic effects of arsenic in vivo. Because the liver is a known target of arsenic, we examined the pathophysiologic and molecular effects of inorganic and organic arsenical exposure on Tg.AC mouse liver in this study. Tg.AC mice were provided drinking water containing As(III), sodium arsenate [As(V)], monomethylarsonic acid [(MMA(V)], and 1,000 ppm dimethylarsinic acid [DMA(V)] at dosages of 150, 200, 1,500, or 1,000 ppm as arsenic, respectively, for 17 weeks. Control mice received unaltered water. Four weeks after initiation of arsenic treatment, TPA at a dose of 1.25 microg/200 microL acetone was applied twice a week for 2 weeks to the shaved dorsal skin of all mice, including the controls not receiving arsenic. In some cases arsenic exposure reduced body weight gain and caused mortality (including moribundity). Arsenical exposure resulted in a dose-dependent accumulation of arsenic in the liver that was unexpectedly independent of chemical species and produced hepatic global DNA hypomethylation. cDNA microarray and reverse transcriptase-polymerase chain reaction analysis revealed that all arsenicals altered the expression of numerous genes associated with toxicity and cancer. However, organic arsenicals [MMA(V) and DMA(V)] induced a pattern of gene expression dissimilar to that of inorganic arsenicals. In summary, subchronic exposure of Tg.AC mice to inorganic or organic arsenicals resulted in toxic manifestations, hepatic arsenic accumulation, global DNA hypomethylation, and numerous gene expression changes. These effects may play a role in arsenic-induced hepatotoxicity and carcinogenesis and may be of particular toxicologic relevance.
先前的研究表明,12-O-十四烷酰佛波醇-13-乙酸酯(TPA)处理可增加饮用水中含有亚砷酸钠[As(III)]的v-Ha-ras转基因(Tg.AC)小鼠的皮肤乳头状瘤数量,这表明该模型可用于研究砷在体内的毒性作用。由于肝脏是已知的砷靶器官,因此在本研究中,我们检测了无机和有机砷暴露对Tg.AC小鼠肝脏的病理生理和分子影响。分别以150、200、1500或1000 ppm的砷剂量,为Tg.AC小鼠提供含有As(III)、砷酸钠[As(V)]、一甲基胂酸[MMA(V)]和1000 ppm二甲基胂酸[DMA(V)]的饮用水,持续17周。对照小鼠饮用未改变的水。在砷处理开始四周后,以1.25 μg/200 μL丙酮的剂量,每周两次对所有小鼠(包括未接受砷处理的对照小鼠)剃毛的背部皮肤涂抹TPA,持续2周。在某些情况下,砷暴露会降低体重增加并导致死亡(包括濒死状态)。砷暴露导致肝脏中砷的剂量依赖性积累,这出乎意料地与化学物种无关,并导致肝脏整体DNA低甲基化。cDNA微阵列和逆转录聚合酶链反应分析表明,所有砷化合物均改变了许多与毒性和癌症相关基因的表达。然而,有机砷化合物[MMA(V)和DMA(V)]诱导的基因表达模式与无机砷化合物不同。总之,Tg.AC小鼠亚慢性暴露于无机或有机砷化合物会导致毒性表现、肝脏砷积累、整体DNA低甲基化以及众多基因表达变化。这些影响可能在砷诱导的肝毒性和致癌作用中起作用,并且可能具有特殊的毒理学相关性。